Total population Total population Total population Symptomatic infection Symptomatic infection Symptomatic infection
Influenza (n=295) SARS-CoV2 (n=133) p value Influenza (n=293) SARS-CoV2 (n=103) p value
Male sex, n (%) 155 (52.5%) 74 (55.6%) 0.60+ 139 (47.4%) 46 (44.7%) 0.65
Age, median (IQR) 3.7 (1.4-7-7) 5.3 (1.1-11.2) 0.093 5.3 (4.7) 7.3 (5.8) 0.002
Any comorbidity Cardiovascular Asthma Pulmonary Immunodeficiency Kidney disease Cancer Congenital malformations 285 (96.6%) 56 (19%) 17 (5.8%) 42 (14.2%) 92 (31.2%) 29 (9.8%) 85 (28.8%) 88 (17.6%) 110 (82.7%) 17 (12.8%) 5 (3.7%) 5 (3.8%) 33 (24.8%) 12 (9%) 28 (21%) 10 (7.5%) <0.001 0.13 0.48 0.001 0.21 0.86 0.09 0.007 283 (96.6%) 55 (18.8%) 17 (5.8%) 42 (14.3%) 92 (31.4%) 29 (9.9%) 85 (29%) 52 (17.7%) 85 (82.5%) 13 (12.6%) 4 (3.9%) 4 (3.9%) 25 (24.3%) 10 (9.7%) 21 (20.4%) 9 (8.7%) <0.001 0.17 0.61 0.004 0.21 1 0.09 0.038
Nutritional status Undernourished Overweight/Obesity 88/290(30.3%) 59/290(20.3%) 41/131(31.3%) 22/131(16.8%) 0.69 .. 87/288 (30.2%) 59/288 (20.5%) 19/103(28.2%) 19/103(18.4%) 0.77 ..
Nosocomial acquisition 91 (30.8%) 25 (18.8%) 0.010 89 (30.4%) 13 (12.6%) <0.001
Symptoms at diagnosis Asymptomatic Fever Cough Pharyngodynia Headache Myalgia Laboured breathing Rhinorrhea Vomiting Diarrhea 2 (0.7%) 248 (84.1%) 222 (75.2%) 25 (8.5%) 25 (8.5%) 11 (3.7%) 134 (45.4%) 157 (53.2%) 42 (14.2%) 31 (10.5%) 30 (22.6%) 78 (58.6%) 31 (23.3%) 3 (2.3%) 11 (8.3%) 6 (4.5%) 35 (26.3%) 6 (4.5%) 30 (22.6%) 18 (13.5%) <0.001 <0.001 <0.001 0.018 1 0.79 <0.001 <0.001 0.037 0.41 248 (84.6%) 222 (75.8%) 25 (8.6%) 25 (8.5%) 11 (3.7%) 134 (45.7%) 157 (53.6%) 42 (14.3%) 31 (10.6%) 78 (75.7%) 31 (30.1%) 3 (2.9%) 11 (10.7%) 6 (5.8%) 35 (34%) 6 (5.8%) 30 (29.1%) 18 (17.5%) 0.051 <0.001 0.07 0.55 0.40 0.05 <0.001 0.002 0.08
SaO2 <92% at hospital admission 87 (29.5%) 50 (37.6%) 0.12 86 (29.3%) 42 (40.8%) 0.04
Hypotension 42 (14.2%) 11/130 (8.5%) 0.11 42 (14.3%) 10/100 (10%) 0.31